U.S. Markets close in 25 mins
  • S&P 500

    4,527.96
    -49.14 (-1.07%)
     
  • Dow 30

    34,519.48
    -120.31 (-0.35%)
     
  • Nasdaq

    15,039.06
    -342.26 (-2.23%)
     
  • Russell 2000

    2,148.83
    -57.51 (-2.61%)
     
  • Crude Oil

    65.94
    -0.56 (-0.84%)
     
  • Gold

    1,785.80
    +23.10 (+1.31%)
     
  • Silver

    22.54
    +0.22 (+1.00%)
     
  • EUR/USD

    1.1311
    +0.0005 (+0.0452%)
     
  • 10-Yr Bond

    1.3430
    -0.1050 (-7.25%)
     
  • Vix

    32.78
    +4.83 (+17.28%)
     
  • GBP/USD

    1.3233
    -0.0069 (-0.5161%)
     
  • USD/JPY

    112.7890
    -0.4200 (-0.3710%)
     
  • BTC-USD

    53,179.13
    -3,967.11 (-6.94%)
     
  • CMC Crypto 200

    1,346.88
    -94.88 (-6.58%)
     
  • FTSE 100

    7,122.32
    -6.89 (-0.10%)
     
  • Nikkei 225

    28,029.57
    +276.20 (+1.00%)
     

Will Johnson & Johnson Win Authorization for Its COVID-19 Booster?

·4 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

A U.S. Food and Drug Administration (FDA) advisory committee has reviewed Johnson & Johnson's (NYSE: JNJ) data supporting boosters of its COVID-19 vaccine. The FDA gets the final say in the matter, though. In this Motley Fool Live video recorded on Oct. 6, Motley Fool contributors Keith Speights and Brian Orelli discuss J&J's prospects for authorization of boosters.